Close
Novotech
Jabsco PureFlo 21 Single Use

Press Releases

Medpharm Opens State Of The Art Manufacturing Facility in Durham, NC (RTP)

MedPharm Ltd, a world-leading contract developer of topical and transdermal pharmaceutical products, is opening a new location in Raleigh-Durham, North Carolina that will expand its CDMO services in topical and transdermal delivery. Doubling its existing footprint, the facility will support...

Aptamer and PinotBio collaborate to develop new therapeutic drug conjugates

Aptamer Group Limited, the developer of Optimer™ Therapeutics, and PinotBio (Gyeonggi-do, Korea), a clinical-stage oncology-focused biotechnology company, announce that they have entered into a strategic collaboration agreement. The agreement is to develop Optimer-drug conjugates for targeted drug delivery combining...

Moderna Announces Agreement with Thermo Fisher Scientific for Fill/Finish Manufacturing of Moderna’s COVID-19 Vaccine

Moderna, Inc. , a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines,  announced that it has entered into an agreement with Thermo Fisher Scientific for fill/finish sterile manufacturing services and supply packaging for Moderna’s COVID-19 vaccine. Under the terms...

Moderna Announces New Drug Substance Production Agreement with Lonza in the Netherlands

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that it has entered into an additional agreement with Lonza to support drug substance manufacturing for its global supply chain. The agreement will establish a new...

World Health Organization Authorizes SINOVACs CoronaVac for Emergency Use

SINOVAC Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that CoronaVac®, an innovative, inactivated coronavirus vaccine developed by SINOVAC Life Sciences Co., Ltd., a subsidiary of the Company, was approved for emergency use under the World...

Greenphire Announces Strategic Growth Investment from Thoma Bravo

Thoma Bravo, a leading private equity investment firm focused on the software and technology-enabled services sector, announced that it has reached an agreement to acquire Greenphire, the global leader in financial lifecycle management software for clinical trials, from The...

Exscientia announces multi-target, AI-driven drug discovery collaboration with Bristol Myers Squibb

Exscientia, the clinical stage, Artificial Intelligence (AI)-driven pharmatech company, announced that it has entered into a collaboration agreement with Bristol-Myers Squibb Company. This expanded collaboration has the potential to add to the Bristol Myers Squibb drug pipeline whilst enhancing...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »